Questions remain over Canada's vaccination drive amid delays and fresh applications
Canada's national vaccine rollout seems poised to dominate COVID-19 discussions in the coming week as Canada enters the 11th month of life during a global pandemic.
The federal government, which is overseeing the nationwide effort, has been facing strong criticism as it struggles to ensure there are enough immunization doses to go around.
The two companies whose vaccines have been approved for use here recently complicated matters by saying they wouldn't immediately be able to deliver their promised number of doses due to production delays in Europe.
The Liberal government has repeatedly said both Pfizer-BioNTech and Moderna still intend to fulfill their promised delivery schedules and that current delays are temporary.
At least three other companies, Novavax, Astra-Zeneca and Johnson and Johnson, have all launched the process of having Health Canada approve their vaccines.
Canada officially recorded more than 20,000 deaths caused by COVID-19 as of Sunday and is still logging high daily case counts in several provinces, though Chief Public Health Officer Dr. Theresa Tam says overall totals are trending downward.
-
First shipment of AstraZeneca vaccine arrives amid confusion over its use for seniors
Canada is to receive 500,000 doses of the vaccine, the third approved for use in Canada, from the Serum Institute of India. -
New COVID-19 measures take effect in nine Ontario regions, two move into lockdown
The Thunder Bay and Simcoe-Muskoka health units have seen infections rising in recent days, driven in part by transmission of more infectious variants of the virus. -
UPDATE: Tiger Woods awake, responsive, and recovering after crash
Doctors tried to stabilize ``significant'' injuries to his right leg with rods and a combination of screws and pins
